PACIRA BIOSCIENCES, INC. Goodwill, Acquired During Period
PACIRA BIOSCIENCES, INC. (PCRX) reported Goodwill, Acquired During Period of $17.99 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2026-02-26
- PACIRA BIOSCIENCES, INC. goodwill, acquired during period for the quarter ending 2019-12-31 was $0.00.
- PACIRA BIOSCIENCES, INC. goodwill, acquired during period for the quarter ending 2019-09-30 was -$991.00K.
- PACIRA BIOSCIENCES, INC. goodwill, acquired during period for fiscal 2025 was $17.99M.
- PACIRA BIOSCIENCES, INC. goodwill, acquired during period for fiscal 2019 was $37.51M.
| Period end | Goodwill, Acquired During Period 1 month | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $17.99M 10-K · filed 2026-02-26 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$991.00K derived: sum of 2 quarters · filed 2021-03-01 | $37.51M 10-K · filed 2021-03-01 | ||
| 2019-09-30 | -$991.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $37.51M 10-Q · filed 2019-11-08 | |||
| 2019-06-30 | $38.50M 10-Q · filed 2019-08-08 | ||||
| 2012-04-30 | $8.00M 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |